enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Pertuzumab/trastuzumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab/trastuzumab/...

    The fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase was approved for medical use in the United States in June 2020. [5] [10]The FDA's approval was based on the results of a non-inferiority study in participants with HER2-positive early breast cancer, which demonstrated the fixed-dose combination of pertuzumab, trastuzumab, and hyaluronidase had comparable efficacy and ...

  3. Trastuzumab/hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Trastuzumab/hyaluronidase

    This pharmacology -related article is a stub. You can help Wikipedia by expanding it.

  4. Pertuzumab - Wikipedia

    en.wikipedia.org/wiki/Pertuzumab

    Pertuzumab is administered as an intravenous infusion in combination with trastuzumab and docetaxel as a first line treatment for HER2-positive metastatic breast cancer. [4] [3] It is also used in the same combination as a neoadjuvant (given to reduce the size of a tumor, prior to surgery or radiation) for HER2-positive early breast cancer; as of 2016 this use had not been shown to increase ...

  5. Trastuzumab - Wikipedia

    en.wikipedia.org/wiki/Trastuzumab

    Trastuzumab costs about US$70,000 for a full course of treatment. [80] Australia has negotiated a lower price of A$50,000 per course of treatment. [81] Since October 2006, trastuzumab has been made available for Australian women and men with early-stage breast cancer via the Pharmaceutical Benefits Scheme. This is estimated to cost the country ...

  6. Vismodegib - Wikipedia

    en.wikipedia.org/wiki/Vismodegib

    Vismodegib, sold under the brand name Erivedge, is a medication used for the treatment of basal-cell carcinoma (BCC). [3] The approval of vismodegib on January 30, 2012, represents the first Hedgehog signaling pathway targeting agent to gain U.S. Food and Drug Administration (FDA) approval. [4]

  7. Hyaluronidase - Wikipedia

    en.wikipedia.org/wiki/Hyaluronidase

    A human recombinant hyaluronidase kit, Hyqvia, was approved for use in the European Union in May 2013, [25] and in the United States in September 2014. [26] [27] It is a dual vial unit with one vial of immune globulin infusion 10% (human) and one vial of recombinant human hyaluronidase. [12]

  8. Dying To Be Free - The Huffington Post

    projects.huffingtonpost.com/dying-to-be-free...

    But less than three months into his living on his own, his phone buzzed. An old friend asked if Hamm wanted to get high. The two of them drove to Cincinnati, bought $100 worth of heroin and shot up together in Hamm’s seven-year-old Toyota Camry. Hamm later blamed his relapse on a bad day at work, among other reasons.

  9. Category:Drugs developed by Hoffmann-La Roche - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more